Close Menu

NEW YORK (GenomeWeb) – IBM and JDRF have announced a new collaboration to develop and apply machine learning methods to analyze decades of global type 1 diabetes (T1D) research and mark factors leading to the onset of T1D in children.

The partners said that the collaboration will create an entry point for T1D in the field of precision medicine, combining JDRF's connections to research teams around the world and its prowess in T1D research with IBM's technical capability and computing power.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.